KMI vs RARE · P/E 24, rev $9.30B vs rev $350.0M
Kinder Morgan Inc (KMI) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
KMI currently screens at market cap $62.53B and trailing P/E 24.2. RARE currently screens at market cap $2.79B.
Not investment advice. Open the KMI and RARE stock pages for the full models.
Not investment advice.